Vanessa Williams, 62, opened up about using a GLP-1 in a new Hello! interview.She said taking Mounjaro has been “a game-changer” for her.”My 50s were hard. I started perimenopause in my late forties but suddenly, at 51, it’s crazy how your body changes,” she shared.
Vanessa Williams revealed why taking a GLP-1 has been “a game-changer” as she enters her 60s.
In a new interview with Hello!, the model and actress, 62, shared that she’s been on Mounjaro for the past two years after she noticed changes in her body.
Vanessa Williams on October 26, 2025.
Getty Images
“It’s a game‑changer,” Williams said. “When I turned 60, I was like: ‘I want to be here for a long time, and I want to look my best. So what am I going to do?’”
“My 50s were hard. I started perimenopause in my late forties but suddenly, at 51, it’s crazy how your body changes,” she added. “You feel out of control because you’re working out the same way, eating the same, and your body is not reacting the way it used to.”
Williams also said that she’s started up hormone replacement therapy (HRT) and NAD+ injections, which are thought to be an anti-aging treatment.
Vanessa Williams on February 21, 2025.
Getty Images
“Science is amazing,” the former Miss America shared. “I’m like: ‘What’s next? Bring it on!'”
Several other celebrities, including Oprah Winfrey, Serena Williams, and Meghan Trainor have also opened up about using GLP-1s for weight loss.
“As an athlete and as someone that has done everything, I just couldn’t get my weight to where I needed to be at a healthy place, and believe me I don’t take shortcuts,” Serena told Today back in August. “I do everything but shortcuts.”
She said that the medication helped her drop 31 pounds, citing knee pain as a motivation to lose weight.
Follow us to see more of our stories on Google.
“I had a lot of issues with my knees, especially after I had my kid,” Serena said. “That, quite frankly, definitely had an effect on maybe some wins that I could have had in my career.”
Serena Williams at an Audemars Piguet event on May 28, 2025.
Getty Images